Astrazeneca COVID-19 Vaccine Shown to Cause Serious Neurological Disorder

Scientists have discovered that the AstraZeneca COVID-19 vaccine causes a serious neurological disorder in some recipients that previously was rare.

University College London (UCL) researchers have found that there is a spike in cases of Guillain-Barré syndrome (GBS) in the first 2-4 weeks after the AstraZeneca COVID-19 vaccine is administered in individuals. The researchers did not find the same effect caused by Pfizer or Moderna COVID-19 vaccines.

“It may be that a non-specific immune activation in susceptible individuals occurs, but if that were the case similar risks might apply to all vaccine types,” said UCL professor Michael Lunn, who was the principal author of the study, to explain the rise in GBS cases.

“It is therefore logical to suggest that the simian adenovirus vector, often used to develop vaccines, including AstraZeneca’s, may account for the increased risk,” he added.

Additionally, the Johnson & Johnson Janssen vaccine is also likely resulting in a spike of GBS cases. Both vaccines deploy a trojan horse delivery system through a weakened chimp adenovirus in order to implant the coronavirus spike protein into recipients.

 

Join the Conversation

Subscribe
Notify of
guest
fas fa-user
fas fa-at
fas fa-link
0 Comments
Inline Feedbacks
View all comments